APPROPRIATENESS OF THERAPY FOR ACTIVE CROHN'S DISEASE: RESULTS OF A MULTIDISCIPLINARY INTERNATIONAL EXPERT PANEL (EPACT II)

(1) Department of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois and University of Lausanne

(2) Healthcare Evaluation Unit, Institute of Social and Preventive Medicine (IUMSP), CHUV and University of Lausanne, Lausanne, Switzerland

(3) Department of Gastroenterology and Hepatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain

(4) n/a, Private Practice, Andernach

(5) Department of Internal Medicine, Robert-Bosch-Krankenhaus, Stuttgart, Germany

(6) Department of Gastroenterology, University of Basle, Basle, Switzerland



This item was part of the IMMFLAMMATORY BOWEL DISEASE II session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A324